CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Atrophy of the Tongue as the Presenting Feature of Metastatic Prostate Cancer
Zreik Abdullah, Maitrey Darrad, Sanjeev Pathak
Int Neurourol J. 2011;15(3):176-178.   Published online 2011 September 30
DOI: https://doi.org/10.5213/inj.2011.15.3.176

Excel Download

Atrophy of the Tongue as the Presenting Feature of Metastatic Prostate Cancer
International Neurourology Journal. 2011;15(3):176-178   Crossref logo
Link1 Link2

Metastatic prostate cancer presenting as an asymptomatic neck mass
Prostate Cancer and Prostatic Diseases. 2005;8(3):293-295   Crossref logo
Link1 Link2 Link3

Metastatic prostate cancer presenting as obstructive jaundice
Urology. 1992;40(5):456-457   Crossref logo
Link1 Link2

No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period
Cancer. 2013;120(6):818-823   Crossref logo
Link1

An unusual presentation of metastatic prostate cancer
BJU International. 2007;92:e20-e20   Crossref logo
Link1

Sequencing Therapies in Metastatic Castration—Resistant Prostate Cancer
Managing Metastatic Prostate Cancer In Your Urological Oncology Practice. 2016;215-230   Crossref logo
Link1

Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer
The Prostate. 2017;77(6):559-572   Crossref logo
Link1 Link2

Metastatic prostate cancer incidence in Australia after amendment to prostate-specific antigen screening guidelines
ANZ Journal of Surgery. 2017;   Crossref logo
Link1 Link2

Baseline atrophy reduces prostate cancer risk
Nature Reviews Urology. 2015;12(9):475-475   Crossref logo
Link1 Link2 Link3

Dose considerations for anti-cancer drugs in metastatic prostate cancer
The Prostate. 2017;77(11):1199-1204   Crossref logo
Link1 Link2